{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:17:58Z","timestamp":1783437478276,"version":"3.54.6"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.1001\/jama.2026.5233","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:30:26Z","timestamp":1779982226000},"page":"73","source":"Crossref","is-referenced-by-count":0,"title":["Nalbuphine for Cough Caused by Idiopathic Pulmonary Fibrosis"],"prefix":"10.1001","volume":"336","author":[{"given":"Yaqun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Chen","sequence":"additional","affiliation":[{"name":"Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Hebei Key Laboratory of Pathogenic Mechanisms and Diagnosis & Treatment Technologies for Lung Microbiome, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"jle260061r1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jama.2025.26179","article-title":"Oral nalbuphine in idiopathic pulmonary fibrosis\u2013associated cough: the CORAL randomized clinical trial.","volume":"335","author":"Molyneaux","year":"2026","journal-title":"JAMA"},{"issue":"9","key":"jle260061r2","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline.","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"jle260061r3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","article-title":"Treatment of interstitial lung disease associated cough: CHEST guideline and expert panel report.","volume":"154","author":"Birring","year":"2018","journal-title":"Chest"},{"issue":"8","key":"jle260061r5","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300083","article-title":"Nalbuphine tablets for cough in patients with idiopathic pulmonary fibrosis.","volume":"2","author":"Maher","year":"2023","journal-title":"NEJM Evid"},{"key":"jle260061r4","unstructured":"Center for Drug Evaluation and Research. The voice of the patient: idiopathic pulmonary fibrosis. March 2015. Accessed April 3, 2026. https:\/\/www.fda.gov\/files\/about%20fda\/published\/The-Voice-of-the-Patient--Idiopathic-Pulmonary-Fibrosis.pdf"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2849516\/jama_liu_2026_le_260061_1782490553.36995.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:12:10Z","timestamp":1783437130000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2849516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,7]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.5233","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}